Community/Retail

Less than 10% of the people who should be taking pre-exposure prophylaxis for HIV are taking the medications.

Though more research is needed, reactivation of the varicella-zoster virus may be caused by a decrease in absolute lymphocytes caused by COVID-19.

It is especially important to better understand the interactions between COVID-19 and acute respiratory distress syndrome.

Two newly discovered antibodies could help in the development of a universal flu vaccine.

Researchers found the largest decreases for heart attack risk among women, which may be because of greater attention paid to women’s heart health in recent decades.

Insurance companies are currently investigating the option of modifying which medications they will cover for HIV pre-exposure prophylaxis (PrEP) therapy, with broad implications for patient access.

A new study found that hypertension is a common comorbidity in patients with COVID-19.

Researchers at Duke University have found that the efficacy of a 2-pronged type 2 diabetes (T2D) treatment increases when the drugs are linked by a heat-sensitive tether rather than simply being concurrently administered, according to a press release.

An overview of the most common human resources problems that pharmacies face and the proactive steps that pharmacies can take to avoid these problems.

A combination treatment was found to be associated with significantly less weight gain and smaller increases in waist circumference than treatment with olanzapine alone.

A trial will enroll up to 60,000 participants to assess the safety and efficacy of a COVID-19 vaccine candidate that only requires a single dose.

A recent study found that patients on immunosuppressive therapy for common skin and rheumatic diseases, such as psoriasis and rheumatoid arthritis, are not at an increased risk for contracting COVID-19.

Pharmacy Times® interviewed Anne Marie Kondic, PharmD, the executive director of the Community Pharmacy Foundation, on the grant opportunities on the horizon that support the practice of pharmacy in the community setting.

In a comprehensive systematic review that assessed risk factors for HZ infection, researchers found that immunosuppression through HIV/AIDS or malignancy places individuals at a significant risk.

New refining process helps to minimize odor and taste from fish oil supplements.

NACDS and NASPA have been encouraging state legislators to promote the critical public health message of the importance of flu vaccination this year.

Pharmacy Times® interviewed Ramzi Yacoub, chief pharmacy officer at SingleCare, on how data from SingleCare has shown an intense surge in demand for the flu vaccine this year.

Seven cases of young people with stiffness throughout their body and an inability to speak presented to hospitals in different cities throughout the country, with seemingly no link between them.

Digital health tools were a major theme during the first-ever NASP Challenge, comprising 4 of the 5 finalists.

Pharmacy Times® interviewed Keri Donaldson, medical director and CEO of Prescient Medicine, about the effects of the COVID-19 pandemic on the opioid epidemic in the United States.

September has been designated as National Sickle Cell Awareness Month for the continued fostering of education surrounding sickle cell disease management.

News consumption was found to be an especially strong predicative factor for acute stress and depression during the COVID-19 pandemic.

Study participants who had dietician sessions, an exercise physiologist session, and online brain training had higher cognition scores after 6 months.

There were a number of FDA approvals in 2019 that were either the first new therapies or first in class approved for certain conditions, and the specialty pipeline is continuing to grow at a rapid pace.

Technology can help revolutionize how a pharmacy manages patients, collects payments, communicates, and can improve overall efficiency.

Agency strongly encourages vaccination of flu amidst COVID-19 pandemic to protect nation’s seniors.

The new study suggests that COVID-19 will follow the track of other respiratory viruses and become seasonal in countries with temperate climates, but only when herd immunity is attained through natural infection or vaccinations.